GALP and polycystic ovary syndrome: This study demonstrates that elevated serum GALP (aOR 1.55) and HMGB1 (aOR 1.65) independently predict GDM development in PCOS pregnancies, with combined biomarker assessment showing superior predictive accuracy (AUC 0.84).